Related Experiment Video

Updated: Aug 8, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 10, 2014

Chemiluminescent enzyme-linked immunoassay for reverse transcriptase, illustrated by detection of HIV reverse

K Suzuki1, B P Craddock, T Kano

  • 1Biomedical Research Center, Olympus Corporation, East Setauket, New York 11733.

Analytical Biochemistry
|May 1, 1993
PubMed

Insights

A new chemiluminescent assay for human immunodeficiency virus 1 reverse transcriptase (RT) offers a sensitive and rapid alternative to traditional methods. This non-isotopic assay demonstrates high correlation with established techniques, reducing assay time significantly.

Area of Science:

  • Biochemistry
  • Virology
  • Assay Development

Background:

  • Reverse transcriptase (RT) is a critical enzyme for human immunodeficiency virus 1 (HIV-1) replication.
  • Traditional RT assays often rely on radioactive isotopes, posing safety and disposal challenges.
  • Developing sensitive, non-isotopic assays is crucial for HIV-1 research and diagnostics.

Purpose of the Study:

  • To develop and validate a novel chemiluminescent assay for quantifying HIV-1 reverse transcriptase (RT) activity.
  • To compare the performance of the new assay with conventional isotopic methods.
  • To assess the assay's utility in detecting RT activity in infected cell samples.

Main Methods:

  • Utilized biotin-labeled oligodeoxythymidylic acid (biotin oligo-dT) and digoxigenin-deoxyuridine triphosphate for non-isotopic labeling.
  • Employed a streptavidin-coated microtiter plate for capturing biotinylated DNA.
  • Incorporated an alkaline phosphatase-conjugated antibody to digoxigenin followed by a chemiluminescent substrate for detection.

Main Results:

  • The chemiluminescent assay showed a strong correlation with established isotopic assays using purified avian myeloblastosis virus RT.
  • Comparison with isotopic RT assays using HTLV-IIIB infected lymphocytes also demonstrated close correlation.
  • The total assay time, excluding the RT reaction, was under 100 minutes.

Conclusions:

  • The developed chemiluminescent assay provides a sensitive and reliable non-isotopic method for HIV-1 RT detection.
  • This assay offers a viable alternative to isotopic methods, with reduced assay time and improved safety.
  • The assay's performance in infected lymphocytes highlights its potential for clinical and research applications.

More Related Videos

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection07:24

Single-Cell Multiplexed Fluorescence Imaging to Visualize Viral Nucleic Acids and Proteins and Monitor HIV, HTLV, HBV, HCV, Zika Virus, and Influenza Infection

Published on: October 29, 2020

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.